<DOC>
	<DOCNO>NCT01554046</DOCNO>
	<brief_summary>The purpose study investigate familial response Methylphenidate treatment ( Ritalin IR ) two aspect : ADHD symptom 's improvement side-effects development .</brief_summary>
	<brief_title>The Effect Methylphenidate Treatment Familial Attention Deficit/Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description>Attention Deficit/Hyperactivity Disorder ( ADHD ) prevalent tend continue childhood adult life . It 's heritability 76 % . It find great ADHD prevalence first-degree family ADHD subjects- 4-6 time general population . Pharmacological treatment first line treatment today ADHD , child adult , Methylphenidate ( specially Ritalin IR ) first medication give disorder . The study include couple first-degree family member , diagnose ADHD . Subjects receive Ritalin IR 4 week undergo several psychiatric cognitive questionnaire time follow-up meeting ( total 3 ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>couple firstdegree family member , diagnose ADHD ( type ADHDNOS ) need medical treatment . subject receive psychiatric medication : antipsychotic medication , antidepressant medication , antianxiety medication mood stabilizer . people suffer psychotic disorder , bipolar disorder severe psychiatric disorder stabilize . Alcohol/drugs addict . people chronic neurologic disease . people Autism mental retardation . people congenital heart defect . people hypertension/tachycardia ( &gt; 100 bpm ) . pregnancy breast feed woman .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder ( ADHD )</keyword>
	<keyword>Methylphenidate- RITALIN IR ( Immediate Release )</keyword>
</DOC>